TCM
Tang Capital Management Portfolio holdings
AUM
$2.02B
1-Year Est. Return
102.23%
This Fund
S&P 500
1 Year Est. Return
+102.23%
AUM
$2.6B
AUM Growth
+$619M
(+31%)
Holding
210
Top Buys
| 1 | +$46M | |
| 2 | +$37.3M | |
| 3 | +$35M | |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$29.3M |
| 5 |
PTC Therapeutics
PTCT
|
+$20.8M |
Top Sells
| 1 | +$38.2M | |
| 2 | +$23.1M | |
| 3 | +$22M | |
| 4 |
CRGX
CARGO Therapeutics
CRGX
|
+$12.6M |
| 5 |
Elanco Animal Health
ELAN
|
+$11.4M |
Sector Composition
| 1 | Healthcare | 94.95% |
| 2 | Consumer Discretionary | 2.06% |
| 3 | Technology | 1.19% |
| 4 | Communication Services | 0.91% |
| 5 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Galectin Therapeutics
GALT
$200M
| – | – |
-12,913
|
|
||
|
HLVX
202
DELISTED
HilleVax
HLVX
| – | – |
-4,920,000
|
|
||
|
ITOS
203
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-3,826,692
|
|
||
204
Seres Therapeutics
MCRB
$82.6M
| – | – |
-13,921
|
|
||
205
Novavax
NVAX
$1.63B
| – | – |
-600,000
|
|
||
|
SWTX
206
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-74,265
|
|
||
|
THRD
207
DELISTED
Third Harmonic Bio
THRD
| – | – |
-929,727
|
|
||
208
Tempest Therapeutics
TPST
$31.1M
| – | – |
-138,962
|
|
||
|
ACTU
209
Actuate Therapeutics
ACTU
$66.5M
| – | – |
-5,243
|
|
||
|
MTSR
210
DELISTED
Metsera Inc
MTSR
| – | – |
-100,000
|
|